Visual Evoked Potentials (VEP) in Graves’ Disease Patients in Siriraj Hospital
Keywords:
Visual evoked potentials, Graves’ disease, subclinical optic neuropathyAbstract
Objective: To evaluate the visual evoked potentials (VEP) in Graves’ disease patients in order to reveal the possible presen- tation of subclinical optic neuropathy.
Methods: Forty-seven Graves’ disease patients without symptoms of optic neuropathy were enrolled. Flash visual evoked potentials (F-VEP) and Pattern visual evoked potentials (P-VEP) were evaluated. Comparison of VEP with normal values was done, between the groups with and without the presentation of eye sign(s) and also among the groups that had differ- ences in thyroid hormone function.
Results: The mean F-VEP amplitude and latency were 17.56±6.20 microvolts (μV) and 114.02±14.92 milliseconds (ms), respectively. The mean P-VEP amplitude and latency were 10.82±4.88 μV and 99.67±5.87 ms, respectively. These values were within normal values. Only the latency of P-VEP was increased significantly (P<0.001) when compared between the groups with (101.81±5.70 ms) and without eye signs (97.43±5.21ms) and it also increased significantly (P=0.033) when compared with normal values. The hyperthyroid group also had a significant increase in the latency of P-VEP when compared to other groups (P=0.002).
Conclusion: Increase in the latency of P-VEP should be sought for and reminded the clinician to conduct close follow-up of this as an early sign of optic neuropathy, especially in the patients with eye manifestation.
Downloads
Published
How to Cite
Issue
Section
License
Users are free to share, copy, and redistribute all articles published in the Siriraj Medical Journal (SMJ) in any medium or format as long as you follow the following terms:
- Attribution — You must give appropriate credit, provide a link to the material, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the publisher endorses you or your use.
- NonCommercial — You may not use the material for commercial purposes.
- NoDerivatives — If you remix, transform, or build upon the material, you may not distribute the modified material.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.